Creation uses Lila Iris and AI Science Factories to generate validated scientific assets and company opportunities.
Creation is Lila's delivery-model offering for partners that bring a problem space or thesis to the company. Lila uses Lila Iris and AI Science Factories to generate hypotheses, design and run experiments, and iteratively optimize candidates.
The offering produces validated assets such as molecular structures, materials, protocols, and data packages that partners can use in pipelines or build into new programs. For investors and strategic partners, Creation campaigns can discover novel molecules, materials, or platforms with technical differentiation, validation, intellectual property, and a de-risked roadmap.
Origin Bio
Origin Bio — Cancer Biology Platform
origin.bio
1910
PEGASUS
1910genetics.com
Insilico Medicine
Pharma.ai
insilico.com
Recursion Pharmaceuticals
Recursion OS
recursion.com
| Attribute | Creation | Origin Bio — Cancer Biology Platform | PEGASUS | Pharma.ai | Recursion OS | |
|---|---|---|---|---|---|---|
| Provider |  | | | | | |
| Founded | 2023 | 2025 | 2018 | 2014 | 2013 | |
| Sells To | Enterprise | B2B, Pharmaceutical Manufacturers | Enterprise | Enterprise | Enterprise | |
| Pricing Model | — | B2B, Licensing | Recurring, Software | Recurring, Software | Recurring, Software | |
| Ownership | Venture-backed private company | Private | Private Equity, Venture Capital | Venture Capital | Public, Venture Capital |
Provider
Founded 2023
Sells To Enterprise
Pricing Model —
Ownership Venture-backed private company
Provider
Founded 2025
Sells To B2B, Pharmaceutical Manufacturers
Pricing Model B2B, Licensing
Ownership Private
Provider
Founded 2018
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Private Equity, Venture Capital
Provider
Founded 2014
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Venture Capital
Provider
Founded 2013
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Public, Venture Capital
ITO Platform
1910.ai
